این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Tanaffos، جلد ۲۴، شماره ۱، صفحات ۱۰۲-۱۰۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Invasive Pulmonary Aspergillosis and Tuberculosis after COVID-19
چکیده انگلیسی مقاله Background: Pulmonary tuberculosis (TB) and invasive aspergillosis are distinct infectious diseases that rarely coexist in the same patient. The concurrent occurrence of these infections presents diagnostic and therapeutic challenges, resulting in complex clinical presentations and potentially adverse outcomes. We present a case report highlighting the diagnostic process, management strategies, and pertinent literature regarding the simultaneous occurrence of pulmonary TB and aspergillosis in a patient following COVID-19 infection.
Case Presentation: A 55-year-old male with a history of occupational exposure as a farmer and welder presented with a complex medical condition. He had a previous COVID-19 infection and was hospitalized for three weeks, receiving appropriate treatment. Subsequently, he developed dyspnea and bilateral pleural effusion and underwent treatment with broad-spectrum antibiotics. Further investigations revealed consolidation in the left upper lobe, and biopsy confirmed the presence of Aspergillus species. The patient received voriconazole treatment for several months, but minimal improvement was observed. Recurrent hemoptysis prompted bronchoscopy, which showed positive results for acid-fast bacilli smear and TB PCR testing, indicating concomitant pulmonary TB. Anti-tuberculosis treatment was initiated alongside ongoing management for aspergillosis.
Conclusion: This case report illustrates the diagnostic and therapeutic complexities associated with the simultaneous occurrence of pulmonary TB and aspergillosis in a patient following COVID-19 infection. Clinicians should maintain a high index of suspicion for dual infections in similar clinical scenarios. Prompt recognition, accurate diagnosis, and individualized treatment strategies are crucial for optimal patient management. Further research is warranted to enhance our understanding of this unique clinical entity and improve patient outcomes.
کلیدواژه‌های انگلیسی مقاله COVID-19,Pulmonary Aspergillosis,Pulmonary Tuberculosis
نویسندگان مقاله Mahshid Talebi-Taher |
Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Seyed- Ali Javad-Moosavi |
Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Shirin Ahmadalipour |
Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Masoud Bahrami |
School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Maryam Sarkheil |
Department of Infectious Diseases, School of Medicine, Iran university of Medical Sciences, Tehran, Iran.

Arash Javad-Moosavi |
Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

نشانی اینترنتی https://www.tanaffosjournal.ir/article_733726_ea3bace49bb4f935a94d855d79ed1bdc.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات